Inflammatory Profiling of Peripheral Arterial Disease

Annals of Vascular Surgery

Volumn 23, Issue 2, 2009, Pages 172-178

  Chaparala, Ramakrishna P C ^a   Orsi, Nicolas M ^b   Lindsey, Nigel J ^c   Girn, Raman S ^a   Homer Vanniasinkam, Shervanthi ^a  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c UNIVERSITY OF BRADFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8;

AGED; ARTERY DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOASSAY; IN VITRO STUDY; INFLAMMATION; LEUKOCYTE COUNT; MALE; PRIORITY JOURNAL;

AGED; ANKLE; ANTIBODIES, ANTICARDIOLIPIN; AUTOANTIBODIES; BETA 2-GLYCOPROTEIN I; BLOOD PRESSURE; BRACHIAL ARTERY; CASE-CONTROL STUDIES; CELLS, CULTURED; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKINS; INTERMITTENT CLAUDICATION; ISCHEMIA; LIPOPOLYSACCHARIDES; PERIPHERAL VASCULAR DISEASES; SEVERITY OF ILLNESS INDEX;

EID: 62549106554     PISSN: 08905096     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.avsg.2008.06.005     Document Type: Article

References (38)

1. Criqui M.H., Fronek A., Barret-Connor E., Klauber M.R., Gabriel S., and Goodman D. The prevalence of peripheral arterial disease in a defined population. Circulation 71 (1985) 510-515
2. Dieter R.S., Chu W.W., Pacanowski Jr. J.P., McBride P.E., and Tanke T.E. The significance of lower extremity peripheral arterial disease. Clin Cardiol 25 (2002) 3-10
3. Leng G.C., Papacosta O., Whincup P., et al. Femoral atherosclerosis in an older British population: prevalence and risk factors. Atherosclerosis 152 (2000) 167-174
4. Murabito J.M., D'Agostino R.B., Silbershatz H., and Wison P.W.F. Intermittent claudication, a risk profile from the Framingham Heart Study. Circulation 96 (1997) 44-49
5. Stratton I.M., Adler A.I., Neil H.A., et al. Association of glycemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 321 (2000) 405-412
6. Newman A.B., Siscovick D.S., Manolio T.A., et al. Ankle-arm index as a marker of atherosclerosis in the cardiovascular health study. Circulation 88 (1993) 837-845
7. Dormandy J., Heeck L., and Vig S. Predictors of early diseases in the lower limbs. Semin Vasc Surg 12 (1999) 109-117
8. Smith F.B., Lee A.J., Hau C.M., Rumley A., Lowe G.D., and Fowkes F.G. Plasma fibrinogen, hemostatic factors and prediction of peripheral arterial disease in the Edinburgh Artery Study. Blood Coagul. Fibrinolysis 11 (2000) 43-50
9. Ridker P.M., Meir J., Stampfe N., and Rifai N. Novel risk factors for systemic atherosclerosis. A comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA 285 (2001) 2481-2485
10. Fiotti N., Giansante C., Ponte E., et al. Atherosclerosis and inflammation. Patterns of cytokine regulation in patients with peripheral arterial disease. Atherosclerosis 145 (1999) 51-60
11. Armitage J.D., Lindsey N.J., and Homer-Vanniasinkam S. The role of endothelial cell reactive antibodies in peripheral arterial disease. Eur J Vasc Endovasc Surg 31 (2006) 170-175
12. Papa N.D., Raschi E., Moroni G., et al. Anti-endothelial cell IgG fractions from systemic lupus erythematosus patients bind to human endothelial cells and induce a pro-adhesive and a pro-inflammatory phenotype in vitro. Lupus 8 (1999) 423-429
13. Shoenfeld Y., Sherer Y., George J., and Harats D. Autoantibodies associated with atherosclerosis. Ann Med 32 Suppl. 1 (2000) 37-40
14. Signorelli S.S., Mazzarino M.C., Di Pino L., et al. High circulating levels of cytokines (IL-6 and TNF-alpha), adhesion molecules (VCAM-1 and ICAM-1) and selectins in patients with peripheral arterial disease at rest and after a treadmill test. Vasc Med 8 (2003) 15-19
15. Hansson G.K. Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J Med 352 (2005) 1685-1695
16. Ganter U., Arcone R., Toniatti C., Morrone G., and Ciliberto G. Dual control of C-reactive protein gene expression by interleukin-1 and interleukin-6. EMBO J 8 (1989) 3773-3779
17. Rus H.G., Vlaicu R., and Niculescu F. Interleukin-6 and interleukin-8 protein and gene expression in human arterial atherosclerotic wall. Atherosclerosis 127 (1996) 263-271
18. Yazici Z.A., Raschi E., Patel A., et al. Human monoclonal anti-endothelial cell IgG derived from a systemic lupus erythematosus patient binds and activates human endothelium in vitro. Int Immunol 13 (2001) 349-357
19. von Aulock S., Schröder N.W., Gueinzius K., et al. Heterozygous toll-like receptor 4 polymorphism does not influence lipopolysaccharide-induced cytokine release in human whole blood. J Infect Dis 188 (2003) 938-943
20. Neumann F.J., Waas W., Diehm C., et al. Activation and decreased deformability of neutrophils after intermittent claudication. Circulation 82 (1990) 922-999
21. Brevetti G., De Caterina M., Martone V.D., et al. Exercise increases soluble adhesion molecules ICAM-1 and VCAM-1 in patients with intermittent claudication. Clin Hemorheol Microcirc 24 (2001) 193-199
22. Kirk G., Hickman P., McLaren M., Stonebridge P.A., and Belch J.J. Interleukin-8 (IL-8) may contribute to the activation of neutrophils in patients with peripheral arterial occlusive disease (PAOD). Eur J Vasc Endovasc Surg 18 (1999) 434-438
23. Wick G., Schett G., Amberger A., Kleindienst R., and Xu Q. Is atherosclerosis an immunologically mediated disease?. Immunol Today 16 (1995) 27-33
24. Yildirir A., and Muderrisoglu H. Non lipid effects of statins. Curr Vasc Pharmacol 2 (2004) 309-318
25. Boisvert W.A., Curtiss L.K., and Terkeltaub R.A. Interleukin-8 and its receptor CXCR2 in atherosclerosis. Immunol Res 21 (2000) 129-137
26. DePalma R.G., Hayes V.W., Cafferata H.T., et al. Cytokine signatures in atherosclerotic claudicants. J Surg Res 111 (2003) 215-221
27. Bonecchi R., Facchetti F., Dusi S., et al. Induction of functional IL-8 receptors by IL-4 and IL-13 in human monocytes. J Immunol 164 (2000) 3862-3869
28. Folcik V.A., Aamir R., and Cathcart M.K. Cytokine modulation of LDL oxidation by activated human monocytes. Arterioscler Thromb Vasc Biol 17 (1997) 1954-1961
29. Goebeler M., Schnarr B., Toksoy A., et al. Interleukin-13 selectively induces monocyte chemoattractant protein-1 synthesis and secretion by human endothelial cells. Involvement of IL-4R alpha and Stat6 phosphorylation. Immunology 91 (1997) 450-457
30. Cimminiello C., Arpaia G., Toschi V., et al. Plasma levels of tumour necrosis factor and endothelial response in patients with chronic arterial obstructive disease or Raynaud phenomenon. Angiology 45 (1994) 1015-1022
31. Uyemura K., Demer L.L., Castle S.C., et al. Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis. J Clin Invest 97 (1996) 2130-2138
32. Brevetti G., Piscione F., Silvestro A., et al. Increased inflammatory status and higher prevalence of three-vessel coronary artery disease in patients with concomitant coronary and peripheral atherosclerosis. Thromb Haemost 89 (2003) 1058-1063
33. Matsuura E., Kobayashi K., Kasahara J., et al. Anti-beta 2-glycoprotein I autoantibodies and atherosclerosis. Int Rev Immunol 21 (2002) 51-66
34. Vaarala O., Manttari M., Manninen V., et al. Anti-cardiolipin antibodies and risk of myocardial infarction in a prospective cohort of middle-aged men. Circulation 91 (1995) 23-27
35. Phadke K.V., Phillips R.A., Clarke D.T., Jones M., Naish P., and Carson P. Anticardiolipin antibodies in ischaemic heart disease: marker or myth?. Br Heart J 69 (1993) 391-394
36. Sletnes K.E., Smith P., Abdelnoor M., Arnesen H., and Wisloff F. Antiphospholipid antibodies after myocardial infarction and their relation to mortality, reinfarction, and non-haemorrhagic stroke. Lancet 339 (1992) 451-453
37. George J., Harats D., Gilburd B., et al. Adoptive transfer of beta(2)-glycoprotein I-reactive lymphocytes enhances early atherosclerosis in LDL receptor-deficient mice. Circulation 102 (2000) 1822-1827
38. Neumann F.J., Waas W., Diehm C., et al. Activation and decreased deformability of neutrophils after intermittent claudication. Circulation 82 (1990) 922-929